China’s State Council Approves Blueprint For Beijing’s National Service Industry Pilot Zone


2023-11-27

In a monumental decision, China’s State Council has officially given the nod to the ambitious plan for constructing the National Service Industry Pilot Zone in Beijing on November 23, 2023. The document charts a course to deepen the development of the national service industry and enhance its global openness—a move that BradyKnows Medical recognizes as a significant leap forward.

The approved plan focuses on supporting and deepening the development of the national service industry and expanding its openness. In the field of health and medical services, the State Council’s response emphasizes the following key points:

  1. Support is provided for eligible foreign and Hong Kong, Macao, and Taiwan doctors to establish clinics in Beijing.
  2. Exploration of equity incentive mechanisms for foreign, Hong Kong, Macao, and Taiwan professionals in stem cell and gene-related medical research and development enterprises.
  3. Support for eligible medical institutions to conduct clinical trials in areas such as stem cells.
  4. Encouragement of international cooperation in stem cell and gene research and development.
  5. Promotion of streamlined management services for human genetic resources for Beijing-based companies in cooperation with Hong Kong and Macao.
  6. Approval facilitation for innovative drugs and medical devices (excluding large medical equipment) for companies registered in Beijing and granted market approval in China, allowing them to be introduced to designated medical institutions based on clinical demand.
  7. Establishment of a green channel for expedited approval of urgently needed imported medical devices in Beijing.
  8. Advancement of the application of real-world data in medical technology research.
  9. Creation of a comprehensive, cross-departmental regulatory system for the entire process of cutting-edge biomedical fields.
  10. Acceleration of risk assessments and quarantine access for bovine-derived Chinese medicinal materials such as bezoar and other materials related to mad cow disease, in response to the development needs of the traditional Chinese medicine and health industry.
  11. Utilization of the national unified medical insurance information platform’s electronic prescription center for prescription circulation.
  12. Exploration of new models for collaborative construction and sharing of health and medical data, with a focus on enhancing standardization and inter-hospital connectivity of clinical medical data.
  13. Deepening of the national comprehensive innovation pilot for rehabilitation assistive devices, promotion of the outcomes of community leasing pilots for rehabilitation assistive devices, support for the research, development, and international cooperation of rehabilitation assistive devices, and promotion of the development of the rehabilitation assistive device industry.
  14. Establishment of an international comprehensive service platform for traditional Chinese medicine, construction of an online trading platform for traditional Chinese medicine, and support for enterprises in expanding international markets.
  15. Seizing the opportunity of China’s participation in the Pharmaceutical Inspection Co-operation Scheme (PIC/S) to promote the high-quality participation of eligible enterprises in international cooperation, including the “Belt and Road” initiative, to facilitate the global expansion of innovative drugs.

This strategic move by the State Council underscores China’s commitment to advancing high-quality development and opening up new avenues for international cooperation within the service industry. The implementation of this plan is anticipated to contribute significantly to the country’s broader goals of modernization and foreign engagement.

As we celebrate this monumental decision, BradyKnows Medical stands ready to contribute to the unfolding narrative of the National Service Industry Pilot Zone. Our commitment to advancing healthcare innovation aligns seamlessly with China’s broader goals of modernization and increased global engagement. Stay tuned as we navigate the exciting developments in this transformative initiative, shaping the future of healthcare in Beijing and beyond (www.bradyknowsmedical.com).